Status:

COMPLETED

Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia

Lead Sponsor:

University Health Network, Toronto

Conditions:

Acute Lymphoblastic Leukemia

Eligibility:

All Genders

18+ years

Brief Summary

Acute lymphoblastic leukemia (ALL) accounts for about 20% of adult leukemias. Treatment results in adult ALL have lagged behind the improvements achieved in the pediatric population. A modified versio...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • previously diagnosed with adult ALL or T-lymphoblastic lymphoma
  • Age \>/= 18
  • Have completed the two-year modified DFCI protocol at least three months earlier and are in continuous complete remission
  • Understand English and are able to fill out questionnaires

Exclusion

    Key Trial Info

    Start Date :

    November 1 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2012

    Estimated Enrollment :

    29 Patients enrolled

    Trial Details

    Trial ID

    NCT01148927

    Start Date

    November 1 2009

    End Date

    October 1 2012

    Last Update

    January 11 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Princess Margaret Hospital

    Toronto, Ontario, Canada, M5G 2M9